FDA labels BD Pyxis cabinet recall Class II after fingerprint scanner found to overheat enough to burn users

The FDA has classified a recall of BD’s Pyxis automated medication cabinets as Class II — the tier the agency uses when a product may cause temporary or medically reversible harm, consistent with the reported first-degree burn risk. The hazard is unusually literal: the fingerprint scanner clinicians press to unlock the cabinet can overheat enough to burn them.

According to the FDA recall database, CareFusion 303, the BD subsidiary that makes the line, issued an Urgent Medical Device Recall on April 30, 2026. The recall reason the agency recorded is blunt: “Fingerprint scanner may overheat to a temperature to cause 1st degree burn.” The agency lists the root cause as “Component design/selection.”

Two records cover the action. The larger, Z-2298-2026, applies to the BD Pyxis MedStation ES and covers 15,933 units in commerce. A companion record, Z-2297-2026, covers the older Pyxis MedStation 4000 and lists a single unit. Both carry product code BRY and name all serial numbers of the affected configurations. (The cabinets themselves are regulated as Class I devices — a designation that describes the product’s risk category, not the severity of this recall.)

A familiar name on the recall list

Rather than pull cabinets from service, CareFusion told facilities to keep dispensing as normal but to stop using the Bio-ID scanner if it feels hot, update local procedures for when the scanner is unavailable, and return a Customer Response Form. Distribution was US nationwide plus roughly twenty other countries, including Spain, the UK, Canada, Australia and Brazil.

The hardware most clinicians never think about — the scanner you tap to pull a dose — is now the part the FDA flagged.

The recall lands against a difficult regulatory backdrop for the Pyxis franchise. In November 2024, the FDA issued BD a warning letter over quality-system violations at the same San Diego operation, according to MedTech Dive’s reporting on the inspection, which cited 111 open software defect tickets classified as catastrophic or severe patient harm and more than 92,000 complaints about system freezes, shutdowns or malfunctions that delayed medication delivery.

The current recall does not involve software or dispensing logic; it is a thermal hardware fault in the biometric reader. But it adds a physical-injury risk to a device line the FDA was already scrutinizing.

Correction (6 June 2026): An earlier version of this story described the recall as Class I, the FDA’s most serious tier. The FDA recall database lists both records (Z-2298-2026 and Z-2297-2026) as Class II; the Class I label applies to the cabinet’s device regulatory category, not to this recall. The headline, standfirst, chart and text have been corrected, and the November 2024 warning-letter figures are now attributed to MedTech Dive’s reporting. Flagged by The Vital Record’s independent verification pass.

This is journalism, not medical or investment advice.